# Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension

> **NCT02216279** · PHASE2 · COMPLETED · sponsor: **Montreal Heart Institute** · enrollment: 45 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** PulmoBind

## Key facts

- **NCT ID:** NCT02216279
- **Lead sponsor:** Montreal Heart Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2015-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02216279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02216279, "Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT02216279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*